Trade Names: | |
Synonyms: | |
Status: | Approved (1960) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N05BA02 |
UNII: | 6RZ6XEZ3CR |
InChI Key | ANTSCNMPPGJYLG-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C16H14ClN3O |
Molecular Weight | 299.76 |
AlogP | 2.95 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 50.46 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 21.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
GABA-A receptor
|
- | 200-910 | - | 275-740 | 74-75 | |
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | - | - | - | 4-35 | |
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Cholecystokinin receptor
|
- | 100000 | - | - | - | |
Membrane receptor
|
- | 100000 | - | 438 | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 25000-44100 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alcoholism | 4 | D000437 | ClinicalTrials |
Substance Withdrawal Syndrome | 3 | D013375 | ClinicalTrials |
Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 58-25-3 |
ChEBI | 3611 |
ChEMBL | CHEMBL451 |
DrugBank | DB00475 |
DrugCentral | 594 |
EPA CompTox | DTXSID4046022 |
FDA SRS | 6RZ6XEZ3CR |
Human Metabolome Database | HMDB0014618 |
Guide to Pharmacology | 3370 |
SureChEMBL | SCHEMBL18474 |
ZINC | ZINC000019632917 |